8-KAcquisitions & DispositionsFinancial EventsExhibits & Filings

CENTENE CORP 8-K Report, Acquisition Completed (May 10, 2005)

Filed May 10, 2005For Securities:CNC

Summary

Centene Corporation (CNC) filed an 8-K on May 10, 2005, to report the completion of its acquisition of the Medicaid assets of SummaCare, Inc., a subsidiary of Summa Health System. This acquisition, initially agreed upon on January 10, 2005, was effective as of May 1, 2005. The transaction involved a cash payment of approximately $21 million and the issuance of 318,735 shares of Centene's common stock. A portion of the cash consideration, $10 million, was financed through Centene's revolving credit facility. This acquisition marks an expansion for Centene in the Medicaid managed care sector. The company has also disclosed that it will file a Form S-3 registration statement to permit the resale of the newly issued shares. The report also details the utilization of its revolving credit facility, noting that $10 million was drawn down for this acquisition, bringing the total outstanding borrowings under the agreement to $40 million. The credit facility has an expiration date of September 14, 2009.

Key Highlights

  • 1Completion of acquisition of SummaCare, Inc.'s Medicaid assets for approximately $21 million in cash and 318,735 shares of common stock.
  • 2Acquisition effective May 1, 2005, following an agreement on January 10, 2005.
  • 3$10 million of the cash purchase price funded by a draw on Centene's revolving credit facility.
  • 4Total outstanding borrowings under the revolving credit facility now stand at $40 million.
  • 5The revolving credit facility has an expiration date of September 14, 2009.
  • 6Centene will file a Form S-3 registration statement for the resale of shares issued in the acquisition.

Frequently Asked Questions

The primary purpose of this 8-K filing was to announce the completion of Centene Corporation's acquisition of the Medicaid assets of SummaCare, Inc., and to disclose the related financing details.

The acquisition was financed through a combination of approximately $21 million in cash and the issuance of 318,735 shares of Centene's common stock. $10 million of the cash portion was funded by borrowing under Centene's revolving credit facility.

The Form S-3 registration statement is to be filed to allow the holders of the 318,735 shares of common stock issued as part of the acquisition consideration to resell those shares in the public market.

Centene drew $10 million from its $100 million revolving credit facility for the acquisition, bringing the total outstanding borrowings under this facility to $40 million. The credit agreement expires on September 14, 2009.